Johnson & Johnson COVID vaccine cleared for expected FDA authorization within days
If the FDA agrees with its review panel, as expected, the one-dose vaccine could begin rolling out to the American public next week.
Stay updated with breaking news from Precision Vaccines Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
If the FDA agrees with its review panel, as expected, the one-dose vaccine could begin rolling out to the American public next week.
>> Benjamin Mueller and Rebecca Robbins, The New York Times Published: 04 Feb 2021 11:31 AM BdST Updated: 04 Feb 2021 11:31 AM BdST FILE -- A volunteer receives the coronavirus vaccine made by AstraZeneca and the University of Oxford in Oxford, England, Nov 20, 2020. Countries are grappling with uncertainties about vaccine supplies and how protective various shots will be, while racing to combat new variants and save lives. (Andrew Testa/The New York Times) First came the good news. The European Union authorised a third vaccine. "); } Then, the bad news. Regulators in country after country...
COVID can infect, sicken and kill small children, too...and leave long-term effects CLINICAL TRIALS for Covid-19 vaccines aren’t expanded soon to include children, it’s unlikely that even kids in their teens will be vaccinated in time for the next school year. The hurdle is that Covid vaccine makers are only in the early stages of testing their products on children. The Pfizer vaccine authorized for use by the Food and Drug Administration two weeks ago was greenlighted only for people ages 16 and up. Moderna just started trials for 12- to 17-year-olds for its vaccine, likely to be au...
Coronavirus vaccine rollout The United States has announced the purchase of 100 million more doses of the BioNTech-Pfizer vaccine. The US has moved faster than many countries in certifying vaccines, giving the green light to two so far. Phil Gayle spoke about the vaccines and their intricacies with Dr. Ofer Levy, the director of the Precision Vaccines Program at Boston Children's Hospital. Watch video 07:03
Should kids be part of COVID-19 vaccine trials? Some pediatricians say yes Much of the debate centers on two issues: the degree of harm COVID-19 causes children, and the extent to which children are spreading the virus to their friends, teachers, parents and grandparents. Written By: Arthur Allen / Kaiser Health News | 7:00 am, Dec. 18, 2020 × Colleen Teevan of Hartford Hospital prepares one of Connecticut's first COVID-19 vaccinations before administering it at Hartford Hospital Monday morning, Dec. 14, 2020. Mark Mirko / Tribune News Service If clinical trials for CO...